MYC and B-cell non-Hodgkin lymphoma: A similar study by Chen et al [14], looking at clinical pathological analysis of B-cell lymphomas concluded that the use of two probe sets with MYC rearrangement and MYC/IGH fusion was detected in 94.2% (81/86) and 83.7% (72/86) cases of BL.